Mimedx (MDXG) EBT Margin (2011 - 2026)

Mimedx's (MDXG) quarterly EBT Margin came in at 25.99% in Q1 2026, down 3575.0% year-on-year from 0.75% in Q1 2025, and down 240.82% quarter-over-quarter from 18.46% in Q4 2025.

Mimedx (MDXG) EBT Margin (2011 - 2026) Analysis & Trends

Mimedx has disclosed EBT Margin across 16 years of filings, most recently posting 25.99% for Q1 2026.

  • EBT Margin for Q1 2026 came in at 25.99%, down 3575.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 10.87% (down 460.0% YoY), and the FY2025 annual result was 15.83%, down 59.0% from the prior year.
  • EBT Margin came in at 25.99% for Q1 2026 at Mimedx, down from 18.46% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 26.62% in Q2 2024 to a low of 25.99% in Q1 2026.
  • The 5-year median for EBT Margin is 12.11% (2024), against an average of 6.15%.
  • Across the five-year window, EBT Margin jumped 2745 bps in 2023 and slumped 3575 bps in 2026, its largest moves.
  • Mimedx's EBT Margin stood at 13.25% in 2022, then grew by 21 bps to 16.02% in 2023, then retreated by 24 bps to 12.11% in 2024, then surged by 52 bps to 18.46% in 2025, then slumped by 241 bps to 25.99% in 2026.
  • The last three EBT Margin figures came in at 25.99% (Q1 2026), 18.46% (Q4 2025), and 20.09% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mimedx 546.28 Mn 386.51 Mn 41.62 Mn -25.99%

Historic Data

Download Data
DateValue
Mar 31, 2026 -25.99%
Dec 31, 2025 18.46%
Sep 30, 2025 20.09%
Jun 30, 2025 13.19%
Mar 31, 2025 9.76%
Dec 31, 2024 12.11%
Sep 30, 2024 13.58%
Jun 30, 2024 26.62%
Mar 31, 2024 13.47%
Dec 31, 2023 16.02%
Sep 30, 2023 11.54%
Jun 30, 2023 11.29%
Mar 31, 2023 -2.64%
Dec 31, 2022 13.25%
Sep 30, 2022 -12.37%
Jun 30, 2022 -16.16%
Mar 31, 2022 -17.70%
Dec 31, 2021 0.18%
Sep 30, 2021 -3.23%
Jun 30, 2021 -2.62%